Physician profile
Son M Bach
NPI 1376758136
$6,998.98
in general payments reported to CMS, 2019-2025
59 companies · $1,373 in 2025
The $1,373 reported for 2025 was more than what 91% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,566 · 2020: $618 · 2021: $1,190 · 2022: $739 · 2023: $648 · 2024: $864 · 2025: $1,373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,886.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,886.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,340.15 | 2019-2025 | Vraylar, Botox, Ubrelvy |
| Amarin Pharma, INC. | $726.92 | 2019-2023 | |
| Novo Nordisk INC | $496.80 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Almatica Pharma LLC | $445.07 | 2022-2025 | Loreev Xr, Teriparatide, Gralise |
| Lilly USA, LLC | $440.26 | 2019-2025 | Zepbound, Mounjaro, Jardiance |
| Pfizer INC. | $363.48 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $231.98 | 2019-2025 | Airsupra |
| Novartis Pharmaceuticals Corporation | $191.77 | 2019-2023 | |
| Amgen INC. | $168.90 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $144.75 | 2019-2022 | |
| Allergan, INC. | $142.68 | 2019-2020 | |
| Exact Sciences Corporation | $130.26 | 2023-2025 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $127.81 | 2019-2025 | Xifaxan |
| Romark Laboratories, Lc | $121.02 | 2019 | |
| Astellas Pharma US INC | $116.04 | 2024-2025 | Veozah |
Show all 59 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Son Bach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.